References
- J. Antimicrob. Chemother v.11 Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections Klastersky, J.;Coppens, L.;P van Auwera and Meunier-Carpentier, F.
- Rev. Infect. Dis. v.3 The Antibacterial action of vancomycin Watanakunakorn, C.
- J. Am. Chem. Soc. v.105 Vacomycin structure and transformation Harris, C.M.;Kopecka, H.
- 강남성모병원 원내 항균제 지침(1999) 강남성모병원
- JAMA v.269 The epidemiology of intravenous vancomycin usage in a university hospital;A 10-year study Ena, J.;Dick, R.W.;Jones, R.N.;Wenzel, R.P.
- J. Antimicrob Chemother. v.15 Vancomycin toxicity;A prospective study Meller, J.A.;Kingdom, J.;Cafferkey, M.
- Arch Intern. Med. v.149 Mild nephrotoxicity associated with vancomycin use Downs, N.J.;Neihart, R.E.;Dolezal, J.M.
- Antimicrob Agents Chemother v.23 Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 Farber, B.F.;Moellering, R.C.
- Antimicrob. Agents Chemother v.36 Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharnacodynamic response Ackerman, B.H.;Vannier, A.M.;Eudy, E.B.
- Ther Drug Monit. v.20 Pharmacodynamics, pharmacokietics, and therapeutic drug monitoring of glycopeptides MacGowan, A.P.
- Antimicrob Agents Chemother v.35 Therapeutic monitoring of antimicrobials;a summary of the information presented at the UKNFQAS for antibiotic assays meeting for participants Reeves, D.S.;MacGowan, A.P.;Holt, H.A.;Lovering, A.M.;Warnock, D.W.;White, L.O.
- Antimicrob Agents Chemother v.34 Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection Peetermans, W.E.;Hoogeterp, J.J.;Hazekamp-Van Dokkum, A.M.
- Ann. Intern. Med. v.94 Vancomycin therapy in patients with impaired renal function;a nomogram for dosage Moellering, R.C.;Krogstad, D.J.;Greenblatt, D.F.
- Antimicrob. Agents Chemother v.25 Pharmacokinetics of vancomycin in patients with various degrees of renal function Matzke, G.R.;McGory, R.W.;Halstenson, C.E.;Keane, W.F.
- Antimicrob Agents Chemother v.32 Vancomycin Pharmacokinetics in patients with various degrees of renal function Rodvold, K.A.
- Am. J. Kidney Dis. v.11 Vancomycin dosing chart for use in patients with renal impairment Brown, D.L.;Mauro, L.S.
- Pharmacotherapy v.5 A simplified dosing method for initiating vancomycin therapy Lake, K.D.;Petersom, C.D.
- Ther Drug Monit. v.16 Vancomycin pharmacokinetics in a patients population;effect of age, gender, and body weight Ducharme, M.P.;Slaughter, R.L.;Edwards, D.J.
- Ther Drug Monit. v.12 Using Clinical data to determine vancomycin dosing parameters Birt, J.K.;Chandler, M.H.H.
- Nephron v.16 Prediction of creatinine clearance from serum creatinine Cockroft, D.W.;Gault, M.H.
- Clin. Pharmacokinet. v.9 Drug therapy in patients undergoing hemodialysis clinical pharmacokinetic considerations Lee, C.C.;Marbury, T.C.
- Clin. Pharm. v.10 Ethnicity and psychotropic drugs Bond, W.S.
- Clin. Pharmacokinet. v.7 Ethnic differences in drug metabolism Kalow, W.
- Clin. Pharmacokinet. v.20 Ethnic differences in drug disposition and responsiveness Wood, A.;Zhou, H.
- Clin. Pharmacol. Ther. v.36 Vancomycin disposition;the importance of age Cutler, N.R.;Narang, P.K.;Lesko, L.J.;Ninos, M.;Power, M.